Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CNTXthis companyContext Therapeutics Inc.	$0.19	-3.87×	2.31×	0×	-2.05×	237.2%	0.0%	0.0%	0.0%	-59.7%	-65.5%	-18.9%	0×	1.82×	0×	8.52×	0.0%	2	-5.64	3	B
CLNNClene Inc.	$4.70	-2.22×	-3.29×	289.36×	-3.38×	-136.4%	78.5%	-11541.5%	-13086.5%	148.8%	-188.6%	-32.1%	-1.23×	-0.75×	-8.61×	0.83×	0.0%	3	-23.9	1	D+
CNTBConnect Biopharma Holdings Limited	$0.72	-2.82×	3.74×	2,452.52×	-2.19×	-12.8%	100.0%	-90740.6%	-86687.5%	-132.2%	-135.7%	-32.9%	0.02×	0.69×	0×	3.74×	0.0%	2	-14.21	2	C+
IMAImageneBio Inc	$3.85	-0.72×	0.28×	46.85×	-0.28×	9.5%	-29.1%	-6056.4%	-5668.6%	-34.1%	-33.4%	-127.6%	0.08×	0.56×	0×	12.49×	0.0%	3	-0.79	3	B
KLRSKalaris Therapeutics Inc	$2.36	-2.96×	1.63×	0×	-0.77×	160.3%	0.0%	0.0%	0.0%	-55.1%	-41.1%	-29.9%	0.02×	2.3×	-31.98×	12.23×	0.0%	1	-2.18	3	B
MGNXMacroGenics, Inc.	$2.38	-1.36×	1.83×	0.68×	-2.54×	-2542.6%	71.1%	-48.7%	-49.9%	-134.2%	-33.0%	-81.6%	1.92×	-0.83×	-8.56×	5.1×	0.0%	1	-4.42	1	D+
Peer median	—	-2.22×	1.63×	46.85×	-2.19×	-12.8%	71.1%	-6056.4%	-5668.6%	-55.1%	-41.1%	-32.9%	0.02×	0.56×	-8.56×	5.1×	0.0%	2	-4.42	2	—